VERGNOLLE; Nathalie

Patent Applications and Registrations

Patent applications and USPTO patent grants for VERGNOLLE; Nathalie.The latest application filed is for "method of treatment of gut inflammatory diseases such as inflammatory bowel diseases (ibd) or irritable bowel syndrome (ibs)".

Company Profile

3.4.6

VERGNOLLE; Nathalie - Toulouse Cedex 3 FR
Vergnolle; Nathalie - Toulouse FR
Vergnolle; Nathalie - Toulouse Cedex FR
VERGNOLLE; Nathalie - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method Of Treatment Of Gut Inflammatory Diseases Such As Inflammatory Bowel Diseases (ibd) Or Irritable Bowel Syndrome (ibs) App 20210040231 - VERGNOLLE; Nathalie ; et al.	2021-02-11
Method of screening a candidate compound for activity as an elastase 2A (ELA2A) inhibitor Grant 10,829,563 - Vergnolle , et al. November 10, 2	2020-11-10
Method Of Treatment Of Gut Inflammatory Diseases Such As Inflammatory Bowel Diseases (ibd) Or Irritable Bowel Syndrome (ibs) App 20190177433 - VERGNOLLE; Nathalie ; et al.	2019-06-13
Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) Grant 9,688,742 - Vergnolle , et al. June 27, 2	2017-06-27
PAR2 agonists for use in the treatment or prevention of influenza virus type A infections Grant 9,125,861 - Vergnolle , et al. September 8, 2	2015-09-08
Recombinant Probiotic Bacteria For The Prevention And Treatment Of Inflammatory Bowel Disease (ibd) And Irritable Bowel Syndrome (ibs) App 20150073125 - Vergnolle; Nathalie ; et al.	2015-03-12
Recombinant Probiotic Bacteria For The Prevention And Treatment Of Inflammatory Bowel Disease (ibd) And Irritable Bowel Syndrome (ibs) App 20130344033 - Vergnolle; Nathalie ; et al.	2013-12-26
Recombinant Probiotic Bacteria For The Prevention And Treatment Of Inflammatory Bowel Disease (ibd) And Irritable Bowel Syndrome (ibs) App 20120195859 - VERGNOLLE; Nathalie ; et al.	2012-08-02
PAR2 Agonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections App 20120058127 - Vergnolle; Nathalie ; et al.	2012-03-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.